Del(1p32) is an early and high-risk event in multiple myeloma patients with extraosseous disease.
Stork M, Ondrouskova E, Bohunova M, Boichuk I, Fric D, Adam Z, Krejci M, Sandecka V, Knechtova Z, Radova L, Jelinkova Z, Adlerova T, Krticka M, Nekuda V, Borsky M, Sevcikova S, Jarosova M, Pour L.
Stork M, et al. Among authors: sevcikova s.
Blood Cancer J. 2024 Aug 26;14(1):146. doi: 10.1038/s41408-024-01131-6.
Blood Cancer J. 2024.
PMID: 39187485
Free PMC article.
No abstract available.